Breaking News

You are here » Indian-Commodity  :  Corporate  :  Glenmark Pharmaceuticals enters into exclusive agreement with Cyndea Pharma

19-Jul2017

Glenmark Pharmaceuticals enters into exclusive agreement with Cyndea Pharma

Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products.

Under this agreement, Glenmark receives exclusive rights to the United States and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales. In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialization, as new branded, soft gelatin, capsule-based drug products become available in the marketplace.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of oncology, dermatology and respiratory.



Related News

View all news

DCB Bank reports 25% rise in Q2 net profit

DCB Bank has reported results for second quarter ended September 30, 2018.The Bank has reported 24.69% rise in its net profit at Rs 73.44 crore for the quarter under review as compared to Rs 58.90 crore......

Persistent Systems, Partners HealthCare launch new center of excellence

Partners HealthCare in collaboration with Persistent Systems has formed a new center of excellence - Partners HealthCare Pivot Labs that aims to disrupt the delivery of healthcare to enhance the patient......

IndiGo makes Hong Kong as its 15th international destination

InterGlobe Aviation (IndiGo) has made Hong Kong as its 15th international destination. The airline to operate its daily non-stop flight between Hong Kong and Bangalore effective December 11, 2018. As part......

Top News

View all news

IRB Infrastructure's arm achieves financial closure for Vadodara-Mumbai Expressway project

IRB Infrastructure Developers' Wholly-owned Subsidiary (SPV) -- VK1 Expressway has achieved financial closure for the project of construction of eight lane Vadodara Kim Expressway from Km 355.00 to Km......

Havells India reports 4% rise in Q2 net profit

Havells India has reported results for second quarter ended September 30, 2018.The company has reported 4.44% rise in its net profit at Rs 178.62 crore for the quarter under review as compared to Rs 171.02......

Mphasis reports 37% rise in Q2 consolidated net profit

Mphasis has reported results for second quarter ended September 30, 2018.The company has reported a rise of 9.42% in its net profit of Rs 188.94 crore for the quarter under review as compared to Rs 172.67......